215 articles
Robert S. Sherwin
Robert S. Sherwin (1942–2023) was an American endocrinologist who spent 44 years on the Yale faculty, directed its Diabetes Center, and served as president of the American Diabetes Association.
Roger D. Cone
Roger D. Cone is an American molecular physiologist and neuroscientist known for cloning the melanocortin receptors and showing how the brain's central melanocortin system regulates body weight, work that led to obesity drugs.
Roger H. Unger
Roger H. Unger (1924–2020) was an American endocrinologist and diabetes researcher at UT Southwestern in Dallas, known for the first glucagon radioimmunoassay and the bihormonal hypothesis.
Roman Hovorka
Roman Hovorka is a Czech-born mathematician and Professor of Metabolic Technology at Cambridge, a world leader in the artificial pancreas whose CamAPS FX app is used by over 27,000 people.
Ronald A. Arky
Ronald A. Arky is an American endocrinologist specializing in diabetes and metabolism who holds a distinguished professorship at Harvard Medical School and practices in Boston.
Roy Taylor (diabetologist)
Roy Taylor is a British diabetologist and Emeritus Professor of Medicine and Metabolism at Newcastle University, known for the DiRECT trial showing weight loss puts type 2 diabetes into remission.
Rury R. Holman
Rury R. Holman is a British diabetologist and Emeritus Professor of Diabetic Medicine at Oxford who designed the UKPDS trial and received the American Diabetes Association's 2024 Banting Medal.
Shehzad Basaria
Shehzad Basaria, who publishes as S. Basaria, is an endocrinologist at Brigham and Women's Hospital and Harvard Medical School, first author of the 2010 trial linking testosterone to cardiovascular events.
Shimon Glick
Shimon Glick (born 1932) is an Israeli physician-scientist and endocrinologist who helped found Ben-Gurion University's Faculty of Health Sciences in 1974 and served as its dean.
Shivani Misra
Shivani Misra is a British physician-scientist in diabetes and metabolism at Imperial College London, known for research on early-onset type 2 diabetes and the NHS T2DAY program.
Silva Arslanian
Silva A. Arslanian is a pediatric endocrinologist at the University of Pittsburgh who studies type 2 diabetes and obesity in youth, leading GLP-1 medication trials including liraglutide and semaglutide.
Silvio E. Inzucchi
Silvio E. Inzucchi is an American endocrinologist and diabetes researcher at Yale School of Medicine, where he directs the Yale Diabetes Center and studies diabetes drugs and heart disease.
Simon Heller
Simon R. Heller is a British diabetologist, Professor of Clinical Diabetes at the University of Sheffield, known for research on hypoglycemia and for developing the DAFNE education program.
Soffia Guðbjörnsdóttir
Soffia Guðbjörnsdóttir, born 1962 in Reykjavik, is a Swedish diabetologist and professor of register research at the University of Gothenburg, register holder of the Swedish National Diabetes Register since 2000.
Solomon A. Berson
Solomon A. Berson (1918–1972) was an American physician and endocrinology researcher who co-developed radioimmunoassay for measuring minute quantities of hormones in blood, then chaired medicine at Mount Sinai School of Medicine.
Solomon Tesfaye
Solomon Tesfaye is a consultant physician and Professor of Diabetes Medicine at Sheffield Teaching Hospitals, known for research on the causes and treatment of diabetic neuropathy.
Sophia Zoungas
Sophia Zoungas is an Australian endocrinologist and clinical trialist whose diabetes trials shaped global guidelines, and Executive Director of The George Institute for Global Health Australia from 2026.
Stefan S. Fajans
Stefan S. Fajans (1918–2014) was an American endocrinologist at the University of Michigan who first described maturity-onset diabetes of the young and helped establish that diabetes has several subtypes.
Stefano Del Prato
Stefano Del Prato is an Italian physician-scientist in endocrinology and diabetes, Professor at the University of Pisa from 2001 to 2022 and President of the EASD from 2020 to 2022.
Stephanie A. Amiel
Stephanie A. Amiel, also known as Stephanie Amiel, is a British physician-scientist and Emeritus Professor of Diabetes Research at King's College London, known for hypoglycaemia research and co-creating DAFNE.
Steven E. Shoelson
Steven E. Shoelson is an American physician-scientist at Joslin Diabetes Center and Harvard Medical School known for identifying inflammation as a mediator of insulin resistance in type 2 diabetes.
Steven M. Haffner
Steven M. Haffner is an American endocrinologist and diabetes epidemiologist at the University of Texas Health Science Center in San Antonio, known for the San Antonio Heart Study.
Susumu Seino
Susumu Seino (清野 進, 1948–2021) was a Japanese molecular physiologist at Kobe University who defined the β-cell KATP channel and discovered Epac2, winning the 2018 Japan Academy Prize.
Takashi Kadowaki
Takashi Kadowaki (門脇孝) is a Japanese diabetes researcher and president of Toranomon Hospital, known for discovering the adiponectin receptors and winning the 2013 Japan Academy Prize.
Thomas J. Merimee
Thomas J. Merimee is an endocrinologist who studied the growth hormone–IGF axis, showing growth hormone's role in diabetic vascular disease through work on dwarfs and African Pygmies.
Toshimasa Yamauchi
Toshimasa Yamauchi (山内 敏正) is a Japanese diabetes researcher and professor at the University of Tokyo, known for cloning the adiponectin receptors AdipoR1 and AdipoR2.
Willa A. Hsueh
Willa A. Hsueh is an American physician-scientist in endocrinology, diabetes, and metabolism who directs the Diabetes and Metabolism Research Center at Ohio State University, studying how inflammation drives metabolic disease.
William A. Peck
William A. Peck was an American physician-scientist and bone biologist at Washington University School of Medicine who developed the first method for directly studying bone cells.
William C. Knowler
William C. Knowler is an American physician-scientist who led NIDDK's diabetes epidemiology section in Phoenix from 1979 to 2021, known for the Diabetes Prevention Program.
William H. Herman
William H. Herman is an American physician-scientist at the University of Michigan who led economic analyses of the Diabetes Prevention Program and chaired the National Clinical Care Commission.